Factors associated with in-hospital and outpatient survival of patients with different types of stage IV cancer and venous thromboembolism

Edgar Julián Reyes, Paula Ruiz-Talero, Mayra Alejandra Arenas, Catalina Hernández-Flórez, Oscar M. Muñoz

Producción: Contribución a una revistaArtículorevisión exhaustiva

1 Cita (Scopus)

Resumen

OBJECTIVE: To identify factors associated with in-hospital and outpatient survival of patients with different types of stage IV cancer who present with venous thromboembolic disease (VTE).

METHODS: In this prospective cohort, in-hospital and outpatient survival rates up to 180 days were analyzed using Kaplan-Meier curves. Cox regression was used to identify factors associated with different survival functions.

RESULTS: One hundred patients were analyzed (median age, 67.5 years; 75% with Charlson index of <10; 69% with Eastern Cooperative Oncology Group (ECOG) score of 3-4). In-hospital mortality was 18%, and the median time from admission to death was 11 days (interquartile range, 1-61 days). Factors significantly associated with in-hospital mortality were the ECOG score and thrombocytopenia. The 180-day mortality rate was 52%, with deaths mainly occurring in the first 90 days since VTE diagnosis. Additional factors significantly associated with outpatient mortality included male sex and neoplasms with a high risk of thrombosis (lung, pancreas, stomach, uterus, bladder, and kidney neoplasms).

CONCLUSION: Patients with stage IV cancer and acute VTE have short survival. Poor prognostic factors are thrombocytopenia, the ECOG score, and certain types of cancer. These results may help physicians individualize decisions regarding initiation and continuation of anticoagulant therapy.

Idioma originalInglés
Número de páginas12
PublicaciónJournal of International Medical Research
Volumen51
N.º12
DOI
EstadoPublicada - dic. 2023

Huella

Profundice en los temas de investigación de 'Factors associated with in-hospital and outpatient survival of patients with different types of stage IV cancer and venous thromboembolism'. En conjunto forman una huella única.

Citar esto